Literature DB >> 19801959

Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure.

Klaus Golka1, Matthias Hermes, Silvia Selinski, Meinolf Blaszkewicz, Hermann M Bolt, Gerhard Roth, Holger Dietrich, Hans-Martin Prager, Katja Ickstadt, Jan G Hengstler.   

Abstract

Recently, a genome-wide single nucleotide polymorphism association study has identified a sequence variant 30 kb upstream of the c-Myc gene (allele T of rs9642880) that confers susceptibility to bladder cancer. However, the role of exposure to bladder carcinogens has not been considered. This prompted us to analyse the relevance of this polymorphism in 515 bladder cancer cases and 893 controls where the quality and quantity of occupational exposure to bladder carcinogens has been documented. When we analysed a hospital-based case-control series not selected for occupational exposure, rs9642880[T] was influential, in contrast to GSTM1 0/0. However, in a case-control series of patients that have been occupationally exposed to aromatic amines and polycyclic aromatic hydrocarbons, rs9642880[T] was not influential but GSTM1 0/0 was significantly associated with bladder cancer risk. Therefore, the degree to which rs9642880[T] and GSTM1 0/0 confer susceptibility to urinary bladder cancer seems to depend on the extent of exposure to urinary bladder carcinogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801959     DOI: 10.1097/FPC.0b013e328331b554

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  22 in total

1.  The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysis.

Authors:  Jingyuan Tang; Xiao Li; Xuping Jiang; Weizhang Xu; Zhen Xu; Wei Wang; Bianjiang Liu; Qiang Lv; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.

Authors:  Thorunn Rafnar; Sita H Vermeulen; Patrick Sulem; Gudmar Thorleifsson; Katja K Aben; J Alfred Witjes; Anne J Grotenhuis; Gerald W Verhaegh; Christina A Hulsbergen-van de Kaa; Soren Besenbacher; Daniel Gudbjartsson; Simon N Stacey; Julius Gudmundsson; Hrefna Johannsdottir; Hjordis Bjarnason; Carlo Zanon; Hafdis Helgadottir; Jon Gunnlaugur Jonasson; Laufey Tryggvadottir; Eirikur Jonsson; Gudmundur Geirsson; Sigfus Nikulasson; Vigdis Petursdottir; D Timothy Bishop; Sei Chung-Sak; Ananya Choudhury; Faye Elliott; Jennifer H Barrett; Margaret A Knowles; Petra J de Verdier; Charlotta Ryk; Annika Lindblom; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Paolo Vineis; Silvia Polidoro; Simonetta Guarrera; Carlotta Sacerdote; Angeles Panadero; José I Sanz-Velez; Manuel Sanchez; Gabriel Valdivia; Maria D Garcia-Prats; Jan G Hengstler; Silvia Selinski; Holger Gerullis; Daniel Ovsiannikov; Abdolaziz Khezri; Alireza Aminsharifi; Mahyar Malekzadeh; Leonard H van den Berg; Roel A Ophoff; Jan H Veldink; Maurice P Zeegers; Eliane Kellen; Jacopo Fostinelli; Daniele Andreoli; Cecilia Arici; Stefano Porru; Frank Buntinx; Abbas Ghaderi; Klaus Golka; José I Mayordomo; Giuseppe Matullo; Rajiv Kumar; Gunnar Steineck; Anne E Kiltie; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson; Lambertus A Kiemeney
Journal:  Hum Mol Genet       Date:  2011-07-12       Impact factor: 6.150

3.  Effects of PSCA rs2294008 (C/T) and c-MYC rs9642880 (G/T) polymorphisms on bladder cancer: evidence from a meta-analysis.

Authors:  Jie Gao; Peng-Tao Yang; Yan Diao; Hua-Feng Kang; Yang Zhao; Shuai Lin; Zi-Ming Wang; Meng Wang; Xi-Jing Wang; Zhi-Jun Dai
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.

Authors:  Jonine D Figueroa; Stella Koutros; Joanne S Colt; Manolis Kogevinas; Montserrat Garcia-Closas; Francisco X Real; Melissa C Friesen; Dalsu Baris; Patricia Stewart; Molly Schwenn; Alison Johnson; Margaret R Karagas; Karla R Armenti; Lee E Moore; Alan Schned; Petra Lenz; Ludmila Prokunina-Olsson; A Rouf Banday; Ashley Paquin; Kris Ylaya; Joon-Yong Chung; Stephen M Hewitt; Michael L Nickerson; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Núria Malats; Joseph F Fraumeni; Stephen J Chanock; Nilanjan Chatterjee; Nathaniel Rothman; Debra T Silverman
Journal:  J Natl Cancer Inst       Date:  2015-09-14       Impact factor: 13.506

Review 5.  [Occupation-related cancer in urology-Current knowledge including environmental medical aspects].

Authors:  Klaus Golka; Ralf Böthig; Wobbeke Weistenhöfer; Olaf P Jungmann; Steffi Bergmann; Michael Zellner; Wolfgang Schöps
Journal:  Urologie       Date:  2022-09-26

6.  PSCArs2294008 T polymorphism increases the risk of bladder cancer in Bai, Dai, and Han ethnicity in China and a potential mechanism.

Authors:  Junfeng Yang; Wei Li; Zhuorui Zhang; Jie Shen; Ningnan Zhang; Min Yang; Maolin Yang; Yanhong Yu
Journal:  Genes Genomics       Date:  2018-02-03       Impact factor: 1.839

7.  [A critical perspective on the global research activity in the field of bladder cancer].

Authors:  N Schöffel; F Domnitz; D Brüggmann; D Klingelhöfer; M H K Bendels; D A Groneberg
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

8.  Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias.

Authors:  M Felicitas López-Cima; Sara M Alvarez-Avellón; Teresa Pascual; Ana Fernández-Somoano; Adonina Tardón
Journal:  BMC Cancer       Date:  2012-09-27       Impact factor: 4.430

9.  GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.

Authors:  Xuemei Zhang; Maosheng Huang; Xifeng Wu; Susan Kadlubar; Jie Lin; Xinfeng Yu; Chunyang Fan; Baitang Ning; Fred F Kadlubar
Journal:  Pharmgenomics Pers Med       Date:  2013-03-01

10.  Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.

Authors:  Holger Schwender; Silvia Selinski; Meinolf Blaszkewicz; Rosemarie Marchan; Katja Ickstadt; Klaus Golka; Jan G Hengstler
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.